What is NDC 62207-773?

62207-773 is the product NDC for Ranitidine, Ranitidine hydrochloride 150 mg/1 tablet, listed with the FDA by Granules India Ltd. It has 4 package NDCs, shown above in 10- and 11-digit form.

Granules India Ltd, NDC labeler code 62207. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranitidine?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranitidine NDC 62207-773 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62207-773Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62207-0773Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62207-773-36	6220707733662207077336	5 BAG in 1 CARTON (62207-773-36) / 10000 TABLET in 1 BAG (62207-773-32)Marketed from Jun 26, 2019
62207-773-41	6220707734162207077341	1 BOTTLE in 1 CARTON (62207-773-41) / 24 TABLET in 1 BOTTLEMarketed from Jun 26, 2019
62207-773-47	6220707734762207077347	1 BOTTLE in 1 CARTON (62207-773-47) / 500 TABLET in 1 BOTTLEMarketed from Jun 26, 2019
62207-773-58	6220707735862207077358	2 BLISTER PACK in 1 CARTON (62207-773-58) / 10 TABLET in 1 BLISTER PACKMarketed from Jun 26, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranitidine
Generic name (nonproprietary): ranitidine
Active ingredients: Ranitidine hydrochloride — 150 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Granules India LtdNDC labeler code 62207
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210243
Marketing start: Jun 26, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 62207-773_5d3eedfe-cc77-3c4e-e063-6294a90ad1cbSPL ID 5d3eedfe-cc77-3c4e-e063-6294a90ad1cb
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462207077336 followed by a unit qualifier and the quantity

Package 62207-0773-36. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 62207-773

What is NDC 62207-773?: 62207-773 is the product NDC for Ranitidine, Ranitidine hydrochloride 150 mg/1 tablet, listed with the FDA by Granules India Ltd. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranitidine.
What is the active ingredient?: Ranitidine hydrochloride.
Who is the labeler?: Granules India Ltd, NDC labeler code 62207. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranitidine?: 12 other product NDCs are listed under this name. See all Ranitidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranitidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-314	71993-0314-30
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-315	71993-0315-30
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-636	64980-0636-03
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-637	64980-0637-03
Ranitidine	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-109	27241-0109-0627241-0109-50
Ranitidine	Ranitidine hydrochloride 300 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-110	27241-0110-0327241-0110-10
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-0727	00121-0727-16
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-4727	00121-4727-10
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-253	53746-0253-0153746-0253-0553746-0253-10+2 more
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-254	53746-0254-0153746-0254-0253746-0254-30

All 13 Ranitidine NDCs

Other NDCs under ANDA 210243

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210243
Product	Strength	Form · route	Labeler	Product NDC
Ranitidine cool mintranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Granules India Ltd	62207-774